张婧教授现就职于江西中医药大学现代中药制剂教育部重点实验室，获得“江西省新世纪百千万人才工程人才”“江西省青年井冈学者”“江西省杰出青年人才” “湾里区百名先锋、十佳人才”等荣誉，担任国家自然科学基金评审专家、江西省中医药管理局科技计划评审专家、江西省科技奖励评审专家、江西省高新技术企业认定专家、江西省科技专家库专家、江西省省级示范研究生导师创新团队-中药制剂研究生导师创新团队成员，两次前往University of North Carolina at Chapel Hill药学院开展科研合作，并担任国际顶级期刊论文评审专家，同时担任国内多个学术组织理事，包括全国卫生产业企业管理协会治未病分会第二届理事会理事和中国中医药信息学会科技创新与成果转化分会理事，世界中医药学会联合会中药新药创制专业委员会、江西省药学会药剂专业委员会委员等，主持国家级课题5项、省级课题8项，代表性论文如下： [1] Li X, Zhou X, Liu J, Zhang J*, et al. Liposomal co-delivery of PD-L1 siRNA/anemoside B4 for enhanced combinational immunotherapeutic effect. ACS Appl Mater Interfaces. 2022,14(25): 28439-28454. [2] Zhang J, Hu K, Di L, et al. Traditional herbal medicine and nanomedicine: Converging disciplines to improve therapeutic efficacy and human health. Adv Drug Deliv Rev. 2021, 178: 113964. [3] Zhang J, Li X, Huang L*. Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment. Adv Drug Deliv Rev. 2020, 154-155: 245-273. [4] Zhang J, Shen L, Li X, et al. Nanoformulated codelivery of quercetin and alantolactone promotes an antitumor response through synergistic immunogenic cell death for microsatellite-stable colorectal cancer. ACS Nano. 2019, 13(11): 12511-12524. [5] Zhang J, Miao L, Guo S, et al. Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model. J Control Release. 2014, 182: 90-96. | 
